Teratoma with malignant transformation
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
Because teratoma with malignant transformation (TMT) is quite rare, there are no established treatment guidelines. In general, treatment often includes surgery to remove as much of the TMT as possible. Chemotherapy that is specifically designed to target the malignant part of the TMT may also be used.
Last updated: 9/21/2012
- Athanasiou A, Vanel D, El Mesbahi O, Theodore C, Fizazi K. Non-germ cell tumours arising in germ cell tumours (teratoma with malignant transformation) in men: CT and MR findings. European Journal of Radiology. 2009; 69:230-235. http://www.ncbi.nlm.nih.gov/pubmed/19056194. Accessed 9/20/2012.
- El Mesbahi O, Terrier-Lacombe MJ, Rebischung C, Theodore C, Vanel D, Fizazi K. Chemotherapy in patients with teratoma with malignant transformation. European Urology. 2007; 51:1306-1311. http://www.ncbi.nlm.nih.gov/pubmed/17081678. Accessed 9/20/2012.
- ClinicalTrials.gov lists trials that are studying or have studied Teratoma with malignant transformation. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.